An Open-Label Pilot Trial of Alpha Lipoic Acid (ALA) for Weight Loss in Schizophrenia
NCT01355952
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
17
Enrollment
OTHER
Sponsor class
Conditions
Obesity
Weight Loss
Schizophrenia
Interventions
DIETARY_SUPPLEMENT:
Alpha Lipoic Acid
Sponsor
Yale University